Immage Biotherapeutics is a biotechnology company developing cancer immunotherapy through the rapid and efficient development of cutting edge immunotherapy candidates. The company is in the process of developing novel key cancer immunotherapy candidates that can be licensed to the biotechnology and pharmaceutical industry, allowing them the opportunity to develop in vitro proven treatments.
Quote | Impart Media Group Inc. (OTCMKTS:IMMG)
Last: | $1e-06 |
---|---|
Change Percent: | 0.0% |
Open: | $1e-06 |
Close: | $1e-06 |
High: | $1e-06 |
Low: | $1e-06 |
Volume: | 1,000 |
Last Trade Date Time: | 12/31/1969 07:00:00 pm |
News | Impart Media Group Inc. (OTCMKTS:IMMG)
Message Board Posts | Impart Media Group Inc. (OTCMKTS:IMMG)
Subject | By | Source | When |
---|---|---|---|
I was able to sell mine when it | beachbumjeremy | investorshub | 04/22/2021 1:06:49 PM |
I read a story that they attended a | Spurmaker | investorshub | 04/09/2021 12:48:30 AM |
You might want to read https://www.sec.gov/litigation/litreleases/2017/lr23 | Lazarus | investorshub | 02/13/2018 1:43:42 AM |
It's a black hole. Stay away. | Luchador | investorshub | 08/06/2017 8:43:41 PM |
Does anyone have any information about this company? | nope941 | investorshub | 08/06/2017 12:12:44 PM |